Stock PTCT PTC THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
36.36 USD +1.54% Intraday chart for PTC Therapeutics, Inc. -2.26% +31.93%
May. 24 Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing MT
May. 21 Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PTC Therapeutics to Participate at Upcoming Investor Conference
PTC Therapeutics Announces Validation of Sepiapterin European MAA
Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing
Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating
Raymond James Upgrades PTC Therapeutics to Market Perform From Underperform
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Sector Update: Health Care
PTC Therapeutics Says European Commission Seeking Review of Negative Opinion on Translarna
PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation
Transcript : PTC Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:40 AM
Sector Update: Health Care Stocks Steady Premarket Tuesday
Sector Update: Health Care
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application
PTC Therapeutics Gets FDA Priority Review of Upstaza Gene Therapy
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza
PTC Therapeutics : Corporate Presentation – May 2024
PTC Therapeutics to Participate at Upcoming Investor Conferences
North American Morning Briefing : More Earnings -2-
Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTCT Stock
  4. News PTC Therapeutics, Inc.
  5. Other languages